- Home
- STLA vs ALC Comparison
STLA vs ALC Comparison
Compare STLA & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STLA
- ALC
- Stock Information
- Founded
- STLA 2021
- ALC 1945
- Country
- STLA Netherlands
- ALC Switzerland
- Employees
- STLA N/A
- ALC N/A
- Industry
- STLA Auto Manufacturing
- ALC Ophthalmic Goods
- Sector
- STLA Consumer Discretionary
- ALC Health Care
- Exchange
- STLA Nasdaq
- ALC Nasdaq
- Market Cap
- STLA 39.2B
- ALC 43.6B
- IPO Year
- STLA N/A
- ALC N/A
- Fundamental
- Price
- STLA $12.80
- ALC $84.79
- Analyst Decision
- STLA Buy
- ALC Strong Buy
- Analyst Count
- STLA 9
- ALC 14
- Target Price
- STLA $27.34
- ALC $102.53
- AVG Volume (30 Days)
- STLA 10.7M
- ALC 795.5K
- Earning Date
- STLA 02-13-2025
- ALC 11-12-2024
- Dividend Yield
- STLA 12.90%
- ALC 0.31%
- EPS Growth
- STLA N/A
- ALC 156.61
- EPS
- STLA 4.84
- ALC 2.34
- Revenue
- STLA $188,784,956,588.00
- ALC $9,761,000,000.00
- Revenue This Year
- STLA N/A
- ALC $6.14
- Revenue Next Year
- STLA $4.10
- ALC $6.55
- P/E Ratio
- STLA $2.64
- ALC $36.35
- Revenue Growth
- STLA N/A
- ALC 5.25
- 52 Week Low
- STLA $12.12
- ALC $74.30
- 52 Week High
- STLA $29.51
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- STLA 43.02
- ALC 37.98
- Support Level
- STLA $13.15
- ALC $83.80
- Resistance Level
- STLA $13.49
- ALC $88.59
- Average True Range (ATR)
- STLA 0.26
- ALC 1.08
- MACD
- STLA 0.00
- ALC 0.02
- Stochastic Oscillator
- STLA 34.44
- ALC 18.54
About STLA Stellantis N.V.
Stellantis was created out of the merger of US-based Fiat Chrysler Automobiles, or FCA, and French-based Peugeot, or PSA, in January 2021, resulting in the fourth-largest automotive original equipment manufacturer, or OEM, by vehicle sales. In 2023 it sold 6.4 million vehicles, 44% and 30% in Europe and North America, respectively. North America is the most profitable region, contributing 53% of operating income. Its brands include Fiat, Jeep, Chrysler, Ram, Peugeot, Citroen, Opel, Alfa Romeo, and Maserati.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.